Stock Screener

Show:

Sort

Country

Sector

Risk rating

1

2

3

4

5

6

7

Risk factors

Default risk

1

2

3

4

5

6

7

Volatility

1

2

3

4

5

6

7

Stress test

1

2

3

4

5

6

7

Selling difficulty

1

2

3

4

5

6

7

Country risks

1

2

3

4

5

6

7

Other risks

1

2

3

4

5

6

7

Profitability factors

Valuation

1

2

3

4

5

6

7

Analyst view

1

2

3

4

5

6

7

Performance

1

2

3

4

5

6

7

Profitability

1

2

3

4

5

6

7

Growth

1

2

3

4

5

6

7

Dividends

1

2

3

4

5

6

7

Results: 50

Roche Holding AG

Novartis AG

Lonza Group AG

CRISPR Therapeutics AG

Alcon Inc.

BeOne Medicines AG

Sandoz Group AG

Straumann Holding AG

Sonova Holding AG

MoonLake Immunotherapeutics

Galenica AG

Siegfried Holding AG

Tecan Group AG

Oculis Holding AG

Idorsia Ltd

Ypsomed Holding AG

BB Biotech AG

Kuros Biosciences AG

Medacta Group SA

ADC Therapeutics SA

Basilea Pharmaceutica AG

Bachem Holding AG

PolyPeptide Group AG

SKAN Group AG

Santhera Pharmaceuticals Holding AG

DocMorris AG

AC Immune SA

SOPHiA GENETICS SA

Medartis Holding AG

COLTENE Holding AG

DocMorris AG

Molecular Partners AG

Relief Therapeutics Holding SA

IVF Hartmann Holding AG

Aevis Victoria SA

Addex Therapeutics Ltd

EvoNext Holdings SA

GeNeuro SA

Mymetics Corporation

Bionovate Technologies Corp

SES Solar Inc.

VectivBio Holding AG

Achiko AG

Vifor Pharma AG

Altamira Therapeutics Ltd.

Polyphor AG

NewcelX Ltd.

NLS Pharmaceutics AG

ObsEva S.A.

Quotient Limited